"At Christiana Care, we are dedicated to delivering the safest and most effective gynecological treatment and care available. After a complete assessment, a personalized treatment plan is prepared for every patient."

During the past decade, Christiana Gynecologic Oncology LLC conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 52 clinical trials were completed, i.e. on average, 167.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 43 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Christiana Gynecologic Oncology LLC" #1 sponsor was "National Cancer Institute (NCI)" with 38 trials, followed by "SWOG Cancer Research Network" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "Gynecologic Oncology Group" with 7 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Christiana Gynecologic Oncology LLC" #1 collaborator was "National Cancer Institute (NCI)" with 42 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Christiana Gynecologic Oncology LLC" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Recurrent Melanoma" (4 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (4 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "Christiana Gynecologic Oncology LLC" in a lesser frequency.

Most popular intervention types in "Christiana Gynecologic Oncology LLC" are "Drug" (67 trials), "Other" (59 trials), "Biological" (30 trials), "Procedure" (16 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (22 trials), "Carboplatin" (14 trials), "Cisplatin" (11 trials) and "Paclitaxel" (11 trials). Other intervention names were less common.

The vast majority of trials in "Christiana Gynecologic Oncology LLC" are 62 trials for "All" genders and 19 trials for "Female" genders.

Currently, there are NaN active trials in "Christiana Gynecologic Oncology LLC". undefined are not yet recruiting, 5 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Christiana Gynecologic Oncology LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Christiana Gynecologic Oncology LLC, 3 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".